Cancer Home > Ofatumamab

Were you looking for more information about Ofatumumab? Ofatumamab is a common misspelling of ofatumumab.
Ofatumumab (Arzerra®) is a chemotherapy medicine prescribed for the treatment of chronic lymphocytic leukemia (CLL) in people age 18 and older. It is reserved for use in individuals who have not adequately responded to certain other chemotherapy treatment.
Ofatumumab comes as an intravenous (IV) infusion that is administered by a healthcare provider every one to four weeks. You may not be able to use this drug if you have certain allergies or if you are taking certain medications, vitamins, or supplements. Coughing, infections, and fever are among the possible side effects.
(Click Ofatumumab for more information on what this medication is used for, how it works, and what your healthcare provider needs to know before starting treatment with this drug. You can also click any of the links in the box to the right for specific information.)
Written by/reviewed by:
Last reviewed by: Kristi Monson, PharmD;
Last updated/reviewed:
List of references (click here):
Other Articles in This eMedTV Presentation




Related Channels

eMedTV Links
Copyright © 2006-2019 Clinaero, Inc.

eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.

This site complies with the HONcode standard for trustworthy health information:
verify here.